A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world.
No Comments »
Filed under: Pharmacy News
The Stem Cells and Cancer Research Group headed by Dr H-ctor G. Palmer at the Vall d’Hebr-n Institute of Oncology (VHIO) has identified the molecular mechanisms that determine patients’ response to certain drugs used in clinical trials for colon cancer treatment. The study led by VHIO also benefited from the collaboration with Professor Alberto Mu-oz-s [...]
No Comments »
Filed under: Pharmacy News
Santarus, Inc. today announced that safety and efficacy data from a Phase III, double-blind, multicenter, placebo-controlled 12 month extended use study with the investigational drug UCERIS (budesonide) 6 mg tablets will be featured in four poster presentations at the Digestive Disease Week (DDW) Meeting being held at the San Diego Convention Center on May 19 [...]
No Comments »
Filed under: Pharmacy News
In this post on her blog, “The Garrett Update” — the last of a series of posts examining the safety of drugs and vaccines — Laurie Garrett, senior fellow for global health at the Council on Foreign Relations (CFR), further details the key findings of the CFR’s Policy Innovation Memorandum No. 21, a six-point policy [...]
No Comments »
Filed under: Pharmacy News
Sigmoid Pharma Ltd., a privately-owned, specialty pharmaceutical and drug delivery company registered in Ireland, today provides an update on significant progress in 2011 and 2012.
No Comments »
Filed under: Pharmacy News
Active Biotech and Ipsen will present tasquinimod (TASQ), their prostate cancer drug candidate, at the scientific conference “2012 ASCO Annual Meeting” to be held in Chicago (USA) on 1-5 June 2012.
No Comments »
Filed under: Pharmacy News
GlobalPost’s “Global Pulse” blog reports on a potential public-private partnership that aims to bring tuberculosis (TB) vaccine trials to the gold mines of Southern Africa, where, “for every 100,000 workers …, 3,000 have tuberculosis, and many have often-fatal, drug-resistant strains of TB.”
No Comments »
Filed under: Pharmacy News
The U.S. Food and Drug Administration (FDA) generally approves drug therapies faster and earlier than its counterparts in Canada and Europe, according to a new study by Yale School of Medicine researchers. The study counters perceptions that the drug approval process in the United States is especially slow. Led by second-year medical student Nicholas Downing [...]
No Comments »
Filed under: Pharmacy News
Digestive Care, Inc. (DCI), announced that the company has received U.S. Food and Drug Administration (FDA) approval of its New Drug Application (NDA) for PERTZYE, indicated for the treatment of Exocrine Pancreatic Insufficiency (EPI) due to cystic fibrosis (CF) or other conditions.
No Comments »
Filed under: Pharmacy News
Ameritox, the nation’s leader in pain medication monitoring, announced today the presentation of a peer-reviewed scientific poster titled “Patterns of Drug Use in the Older Chronic Pain Population” at the American Pain Society Annual Meeting.
No Comments »
Filed under: Pharmacy News
